UK judge to rule on foreign patent infringement

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

UK judge to rule on foreign patent infringement

A judge sitting in the High Court in London has said he can rule on whether patents in France, Germany, Italy and Spain are infringed in a single trial in the UK

In a dispute between Actavis and Eli Lilly, Mr Justice Arnold this week accepted Actavis’s submission that there were good reasons to hear all the related infringement cases in the England & Wales court.

[I]n my judgment Lilly has not shown that the courts of France, Germany, Italy and Spain are the appropriate fora for the trial of Actavis’ claims in relation to the French, German, Italian and Spanish designations of the Patent. Certainly I do not consider that it has shown that those courts are clearly or distinctly more appropriate than this Court. Accordingly, I would decline to grant a stay of those claims on the grounds of forum non conveniens,” said the judge.

The dispute concerns the national designations of Eli Lilly’s European patent 1 313 508 for the use of pemetrexed disodium. Actavis seeks a declaration that it can produce pemetrexed dipotassium without infringing the patents .

Eli Lilly sells its version of the drug as a cancer treatment using the brand Alimta.

The opportunity for courts to rule on the infringement of foreign IP rights was opened up by the UK Supreme Court’s copyright decision in Lucasfilm v Ainsworth last year. Arnold argued in his judgment that patent rights should essentially be treated the same as copyright.

According to Lucasfilm, UK courts cannot rule on the validity of foreign IP rights.

In this case, Actavis deliberately did not ask the court to rule on the (in)validity of the patent. However, it is a party to opposition proceedings at the EPO in which the validity is challenged. As Arnold said parenthetically: “In effect, therefore, the Actavis group has voluntarily bifurcated the infringement and validity aspects of its case with respect to the Patent .”

Bifurcation of validity and infringement proceedings is common in Germany, but not in the UK and is in fact criticised by many UK practitioners.

Actavis is represented by Bird & Bird, Richard Meade QC and Thomas Raphael and Eli Lilly by Hogan Lovells, Stephen Phillips QC and Thomas Mitcheson. Bird & Bird has published an article analysing the ruling.

Eli Lilly is expected to appeal the decision to the Court of Appeal. If the decision is upheld, the judge will have to hear evidence and then rule on whether the various patents are infringed by Actavis’s proposed activities. The company wants to enter the market by the end of 2015.

more from across site and SHARED ros bottom lb

More from across our site

Professionals from three organisations reveal what led them to sponsor Brand Action and why doing so can build camaraderie
The results of a UK government consultation on the exhaustion of IP rights and an annual review published by the EPO’s Boards of Appeal were also among the top talking points this week
The decision disregards Perlmutter’s work at the US Copyright Office and comes at a time when strong leadership and expertise are crucial
Sources say the decision to fire Shira Perlmutter raises constitutional concerns and speculate on what the decision could mean for the country’s approach to AI
India has formally liberalised its legal market, allowing foreign firms to open offices in the country and provide advisory services
Rachelle Downie, who joined K&L Gates’s Melbourne office in January, discusses how working at a global firm with a strong life sciences focus is helping her win more business
Alexander Bjørnå, Aera’s first hire in Norway, explains why it’s the right time to disrupt the country’s ‘traditional’ IP market
Natasha Ahmed said she was drawn to the firm’s commitment to artificial intelligence and tech transactions
As it celebrates its 50th anniversary this year, the firm discusses private equity interest in IP, why the UPC is a key priority, and being a ‘strategic adviser’ to clients
Thomas Rukin discusses IP due diligence, his joy at seeing colleagues succeed, and taking inspiration from Marcus Aurelius
Gift this article